Invesco Pharmaceuticals ETF
PJP
96 hedge funds and large institutions have $59.3M invested in Invesco Pharmaceuticals ETF in 2025 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 29 reducing their positions, and 6 closing their positions.
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
3% more funds holding
Funds holding: 93 → 96 (+3)
1.4% less ownership
Funds ownership: 24.13% → 22.73% (-1.4%)
9% less capital invested
Capital invested by funds: $64.9M → $59.3M (-$5.56M)
38% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
GWN Securities
Palm Beach Gardens,
Florida
|
+$788K |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$643K |
| 3 |
Two Sigma Investments
New York
|
+$409K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$379K |
| 5 |
JWCA
J.W. Cole Advisors
Tampa,
Florida
|
+$248K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$5.19M |
| 2 |
Goldman Sachs
New York
|
-$3.51M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$472K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$403K |
| 5 |
CRI
Commonwealth Retirement Investments
Richmond,
Virginia
|
-$401K |
PJP Hedge Fund Activity: Q1 2025 in Review
96 of the 7,471 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q1 2025, worth a combined $59.3M — down 8.6% from $64.9M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new PJP positions and 6 closed out — a net gain of 5 holders — while 18 added to existing stakes and 29 trimmed.
The largest buyer was GWN Securities, opening a new position worth an estimated $788K. The largest seller was Morgan Stanley, cutting an estimated $5.19M.
- 96 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q1 2025, up from 93 in Q4 2024.
- Funds reported $59.3M of Invesco Pharmaceuticals ETF stock for Q1 2025, down 8.6% quarter-over-quarter.
- 11 funds opened new Invesco Pharmaceuticals ETF positions in Q1 2025 and 6 closed out, a net change of +5 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q1 2025 was GWN Securities, an estimated $788K added.
- The largest Invesco Pharmaceuticals ETF seller in Q1 2025 was Morgan Stanley, an estimated $5.19M sold.
Based on aggregated 13F filings for Q1 2025.